HNGE

Hinge Health, Inc.

$90.00 +1.20 (+1.35%) At close · Jul 13

Market Cap

$6.96B

77,380,129

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$587.86M +50.6%

FY2025

Net Income

-$528.26M -4326.9%

FY2025

Gross Margin

79.65% +2.8pp

FY2025

Operating Margin

-92.94% -84.8pp

FY2025

Diluted EPS

-$7.77 -783%

FY2025

Operating Cash Flow

$171.44M +249.9%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	FY2026 (G)	TTM	FY2025	FY2024	FY2023
Revenue	$798M – $804M	$646.34M	$587.86M	$390.4M	$292.73M
Cost of Revenue	—	$124.12M	$119.64M	$90.5M	$98.55M
Gross Profit	—	$522.22M	$468.22M	$299.9M	$194.18M
Gross Margin	—	—	79.65%	76.82%	66.33%
Research & Development	—	$374.98M	$368.14M	$100.84M	$110.06M
Selling & Marketing	—	$339.04M	$316.95M	$167.06M	$147.62M
General & Administrative	—	$335.65M	$329.51M	$63.92M	$67.02M
Amortization of Intangibles	—	$900K	$900K	$400K	$400K
Depreciation & Amortization	—	—	$5.13M	$5.95M	$5.63M
Total Operating Expenses	—	$1.05B	$1.01B	$331.81M	$324.69M
Operating Income	—	-$527.44M	-$546.37M	-$31.91M	-$130.51M
Operating Margin	—	—	-92.94%	-8.17%	-44.59%
EBITDA	—	—	-$541.24M	-$25.96M	-$124.89M
Other Non-Operating Income	—	$17.98M	$19.11M	$20.65M	$21.97M
Pretax Income	—	-$509.46M	-$527.26M	-$11.26M	-$108.55M
Income Tax	—	$814K	$998K	$677K	-$405K
Net Income	—	-$510.27M	-$528.26M	-$11.93M	-$108.14M
Net Margin	—	—	-89.86%	-3.06%	-36.94%
Net Income Available to Common Stockholders	—	-$511.39M	-$424.09M	-$11.93M	-$108.14M
Comprehensive Income	—	-$510.63M	-$528.35M	-$11.93M	-$108.01M
EPS (Basic) USD/shares	—	—	-$7.77	-$0.88	-$8.31
EPS (Diluted) USD/shares	—	—	-$7.77	-$0.88	-$8.31
Shares Outstanding (Basic Avg) shares	—	—	54.58M	13.56M	13.02M
Shares Outstanding (Diluted Avg) shares	—	—	54.58M	13.56M	13.02M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $65.03M in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

—

Health Information Services median 1.34×

EV/EBIT

—

Health Information Services median 25.06×

P/E (TTM)

—

Health Information Services median 33.12×

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	2025-12-31	2024-12-31	2023-12-31
Reportable Segment	$587,860,000	$390,404,000	$292,730,000

Key facts CIK 1673743 CUSIP 433313103 13F (30d) 5 filings 5 filers Visit website Investor relations